These findings provide molecular evidence that position AKT1, MAPK13, STAT1, and TLR4 as central nodes in the pathophysiology of asthma, justifying future functional studies to delimitate their specific roles and attempt new therapeutic interventions. Here, AKT1 is linked to asthma.